Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Natera Inc (NTRA)
Natera Inc (NTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,609,561
  • Shares Outstanding, K 120,152
  • Annual Sales, $ 820,220 K
  • Annual Income, $ -547,800 K
  • 60-Month Beta 1.18
  • Price/Sales 8.06
  • Price/Cash Flow N/A
  • Price/Book 8.03
Trade NTRA with:

Options Overview Details

View History
  • Implied Volatility 45.41% ( +1.64%)
  • Historical Volatility 47.87%
  • IV Percentile 3%
  • IV Rank 12.31%
  • IV High 78.33% on 11/08/23
  • IV Low 40.79% on 11/22/23
  • Put/Call Vol Ratio 0.03
  • Today's Volume 358
  • Volume Avg (30-Day) 364
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 11,101
  • Open Int (30-Day) 11,148

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.74
  • Number of Estimates 5
  • High Estimate -0.67
  • Low Estimate -0.80
  • Prior Year -1.37
  • Growth Rate Est. (year over year) +45.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.90 +53.50%
on 10/30/23
57.32 -1.19%
on 11/29/23
+18.38 (+48.04%)
since 10/27/23
3-Month
36.90 +53.50%
on 10/30/23
63.00 -10.10%
on 09/01/23
+0.75 (+1.34%)
since 08/29/23
52-Week
35.02 +61.74%
on 01/10/23
63.00 -10.10%
on 09/01/23
+19.13 (+51.00%)
since 11/28/22

Most Recent Stories

More News
Natera: Q3 Earnings Snapshot

Natera: Q3 Earnings Snapshot

NTRA : 56.64 (+2.96%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1429 (+2.07%)
TELO.VN : 0.185 (-7.50%)
GH : 25.12 (+1.33%)
NTRA : 56.64 (+2.96%)
DGX : 135.27 (-0.33%)
NEO : 18.49 (-1.91%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...

TELO.VN : 0.185 (-7.50%)
TDSGF : 0.1429 (+2.07%)
GH : 25.12 (+1.33%)
NTRA : 56.64 (+2.96%)
DGX : 135.27 (-0.33%)
NEO : 18.49 (-1.91%)
Why Natera Stock Is Soaring Today

This DNA testing leader passed the test in Q2.

NTRA : 56.64 (+2.96%)
Natera: Q2 Earnings Snapshot

Natera: Q2 Earnings Snapshot

NTRA : 56.64 (+2.96%)
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -4.24% and 6.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

NTRA : 56.64 (+2.96%)
BDSX : 1.4900 (-0.67%)
Natera: Q1 Earnings Snapshot

Natera: Q1 Earnings Snapshot

NTRA : 56.64 (+2.96%)
Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of a new paper 1 in Cancer Cell from the I-SPY2 trial, highlighting the prognostic and predictive...

NTRA : 56.64 (+2.96%)
Natera Announces First Quarter 2023 Earnings Conference Call

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31, 2023, after the market close on May 9, 2023. Natera...

NTRA : 56.64 (+2.96%)
Apollo Medical Holdings, Inc. (AMEH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Apollo Medical Holdings, Inc. (AMEH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMEH : 33.52 (-0.50%)
NTRA : 56.64 (+2.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 59.69
2nd Resistance Point 58.51
1st Resistance Point 57.57
Last Price 56.64
1st Support Level 55.45
2nd Support Level 54.27
3rd Support Level 53.33

See More

52-Week High 63.00
Last Price 56.64
Fibonacci 61.8% 52.31
Fibonacci 50% 49.01
Fibonacci 38.2% 45.71
52-Week Low 35.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar